Hanall Biopharma Co (XKRX:009420) Land And Improvements : ₩1,494 Mil (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Land And Improvements?

Hanall Biopharma Co's land and improvements for the quarter that ended in Dec. 2023 was ₩1,494 Mil.

Hanall Biopharma Co's quarterly land and improvements stayed the same from Jun. 2023 (₩0 Mil) to Sep. 2023 (₩0 Mil) but then increased from Sep. 2023 (₩0 Mil) to Dec. 2023 (₩1,494 Mil).

Hanall Biopharma Co's annual land and improvements stayed the same from Dec. 2021 (₩1,494 Mil) to Dec. 2022 (₩1,494 Mil) and stayed the same from Dec. 2022 (₩1,494 Mil) to Dec. 2023 (₩1,494 Mil).

Hanall Biopharma Co Land And Improvements Historical Data

The historical data trend for Hanall Biopharma Co's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Land And Improvements Chart

Hanall Biopharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Get a 7-Day Free Trial

1,494.10

Hanall Biopharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Land And Improvements	Get a 7-Day Free Trial															1,494.10	1,494.10	-	-	1,494.10

Hanall Biopharma Co Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Hanall Biopharma Co (XKRX:009420) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Land And Improvements

Traded in Other Exchanges

N/A

Address

12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR

Website

http://www.hanall.co.kr

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines